Compound Evidence File
#EC-2026-0413
BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7
Filed under Raw Materials. The bureau holds 109 laboratory returns for this compound from 36 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
36 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 11 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Dec 2025 | 13 Apr 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Feb 2026 | 5 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Mar 2026 | 25 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Nov 2025 | 21 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 7 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Mar 2026 | 1 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Nov 2025 | 24 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 10.0 | 10.0 | 18 Jun 2026 | 13 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 7 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Apr 2026 | 7 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Jan 2026 | 9 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Dec 2025 | 2 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 19 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Apr 2026 | 22 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Mar 2026 | 1 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 12 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 6 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 14 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 9.9 | 20 Dec 2025 | 14 Aug 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 1 | 9.6 | 9.6 | 9.6 | 2 Jul 2025 | 2 Jul 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 | 27 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 9.0 | 8.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.9 | 8.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.8 | 7.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.0 | 6.7 | 9.9 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 8.0 | 6.1 | 9.7 | 24 May 2026 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 7.3 | 7.3 | 7.3 | 27 Feb 2025 | 27 Feb 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 | 13 Jun 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 6.7 | 6.4 | 6.9 | 2 Apr 2025 | 23 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Jun 2025 | 13 Jun 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 4.8 | 4.8 | 4.8 | 14 Jan 2025 | 14 Jan 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.7 | 0.7 | 0.7 | 2 Jul 2025 | 2 Jul 2025 |
Open any subject to view the batch-level evidence for BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 alone.